Biomarkers

A biomarker can be anything that can be accurately measured as an indicator of normal biological functioning, pathogenic paths or a drug response to a therapeutic drug intervention.  Biomarkers are usually in molecular form. Biomarkers take part in various purposes, including disease diagnosis and prognosis, prediction and calculation of treatment response, and safety evaluation. The   Biomarkers are exclusively being developed and validated to be used in drug development, and used to support approval of drug products.
Biomarkers are mainly classified into Protein biomarkers, Nucleic acid based biomarkers, Lipid biomarkers and Small molecule biomarkers. Almost every pharmaceutical company has been developing biomarker programs. There has been a rapid increase in the number of Biomarkers Congress used in drug delivery over the last decade.

 

  • Protein Biomarkers
  • Nucleic acid biomarkers
  • Lipid biomarkers
  • Small molecule biomarkers

Related Conference of Biomarkers

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in